“A trial of gantenerumab or solanezumab indominantly inherited Alzheimer’s disease- The DIAN-TU-001 Trial Results”
Hosted by the Charles F. and Joanne Knight Alzheimer’s Disease Research Center (Knight ADRC)
Full schedule, Knight ADRC seminars
For inquiries contact Melissa Schicker.